Art
J-GLOBAL ID:200902278880146564   Reference number:07A0058268

Lung Injury Associated with Bortezomib Therapy in Relapsed/Refractory Multiple Myeloma in Japan: A Questionnaire-Based Report from the “Lung Injury by Bortezomib” Joint Committee of the Japanese Society of Hematology and the Japanese Society of Clinical Hematology

日本における再発/難治性多発性骨髄腫でのボルテゾミブ治療と関係した肺傷害:日本血液学会と日本臨床血液学会のボルテゾミブによる肺傷害合同委員会からのアンケートに基づく報告
Author (7):
Material:
Volume: 84  Issue:Page: 406-412  Publication year: Dec. 15, 2006 
JST Material Number: F0888A  ISSN: 0925-5710  CODEN: IJHEEY  Document type: Article
Article type: 原著論文  Country of issue: Germany, Federal Republic of (DEU)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0058268&from=J-GLOBAL&jstjournalNo=F0888A") }}
JST classification (2):
JST classification
Category name(code) classified by JST.
Blood cell tumors(=neoplasms)  ,  Drug therapy(=pharmacotherapy)for tumors 
Substance index (1):
Substance index
Chemical Substance indexed to the Article.
Reference (17):
  • BROSS, PF. Approval summary for bortezomib for injection in the treatment of multiple myeloma. Clin Cancer Res. 2004, 10, 3954-3964
  • JAGANNATH, S. Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma. Br J Haematol. 2005, 129, 776-783
  • RICHARDSON, PG. A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med. 2003, 348, 2609-2617
  • JAGANNATH, S. A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol. 2004, 127, 165-172
  • MIYAKOSHI, S. Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma. Blood. 2006, 107, 3492-3494
more...

Return to Previous Page